Showing results 7 to 26 of 40
< previous
next >
| Issue Date | Title | Author(s) |
| Mar-2024 | C-type lectin-like receptor 2: roles and drug target | Sun, Lan; Wang, Zhe; Liu, Zhiyan; Mu, Guangyan; Cui, Yimin; Xiang, Qian |
| 2019 | Candidate gene and pathway analyses identifying genetic variations associated with prasugrel pharmacokinetics and pharmacodynamics | Liu, Zhiyan; Xiang, Qian; Zhao, Xia; Wang, Zining; Mu, Guangyan; Xie, Qiufen; Zhou, Shuang; Chen, Shuqing; Hu, Kun; Xu, Junyu; Ma, Lingyue; Cui, Yimin |
| Dec-2021 | Candidate Gene of NOS3, MMP3, AGT, and AGT1R and Pathway Analyses for Platelet Reactivity and Clinical Outcomes of Repeat Revascularization After First PCI in Chinese Patients | Zhou, Shuang; Wang, Zhe; Liu, Zhiyan; Mu, Guangyan; Xie, Qiufen; Wang, Zining; Xiang, Qian; Gong, Yanjun; Cui, Yimin |
| 28-Dec-2022 | Circulating miR-320a-3p and miR-483-5p level associated with pharmacokinetic-pharmacodynamic profiles of rivaroxaban | Zhang, Hanxu; Zhang, Zhuo; Liu, Zhiyan; Mu, Guangyan; Xie, Qiufen; Zhou, Shuang; Wang, Zhe; Cao, Yu; Tan, Yunlong; Wei, Xiaohua; Yuan, Dongdong; Xiang, Qian; Cui, Yimin |
| Aug-2021 | Comparison of non-vitamin K antagonist oral anticoagulants on bleeding and thrombosis | Liu, Zhiyan; Ma, Lingyue; Zhang, Hanxu; Mu, Guangyan; Xie, Qiufen; Zhou, Shuang; Wang, Zining; Wang, Zhe; Hu, Kun; Gong, Yanjun; Jiang, Jie; Xiang, Qian; Cui, Yimin |
| Feb-2024 | De-escalation of Antiplatelet Therapy After Percutaneous Coronary Intervention in East Asian Patients With Acute Coronary Syndrome | Li, Wenhui; Zhou, Shuang; Zhang, Hanxu; Wang, Zhe; Mu, Guangyan; Xie, Qiufen; Liu, Zhiyan; Hua, Manqi; Cui, Yimin; Xiang, Qian |
| Nov-2020 | Diagnostic performance of coagulation indices for direct oral anticoagulant concentration | Zhang, Hanxu; Liu, Zhiyan; Mu, Guangyan; Wang, Zhe; Zhou, Shuang; Xie, Qiufen; Ma, Lingyue; Wang, Zining; Hu, Kun; Gong, Yanjun; Jiang, Jie; Xiang, Qian; Cui, Yimin |
| Oct-2020 | Different Coagulation Indicators in Predicting Clinical Outcomes for Patients With Direct Oral Anticoagulants: A Systematic Review and Meta-analysis | Liu, Zhiyan; Zhang, Hanxu; Xie, Qiufen; Mu, Guangyan; Zhou, Shuang; Wang, Zining; Wang, Zhe; Jiang, Jie; Xiang, Qian; Cui, Yimin |
| 17-Mar-2022 | Effect of CYP2C19 genetic polymorphism on the pharmacodynamics and clinical outcomes for patients treated with ticagrelor: a systematic review with qualitative and quantitative meta-analysis | Xie, Qiufen; Xiang, Qian; Liu, Zhiyan; Mu, Guangyan; Zhou, Shuang; Zhang, Zhuo; Ma, Lingyue; Gong, Yanjun; Jiang, Jie; Cui, Yimin |
| Apr-2022 | Effect of Genetic Polymorphism Including NUP153 and SVEP1 on the Pharmacokinetics and Pharmacodynamics of Ticagrelor in Healthy Chinese Subjects | Xiang, Qian; Liu, Zhiyan; Mu, Guangyan; Xie, Qiufen; Zhang, Hanxu; Zhou, Shuang; Wang, Zining; Guo, Ninghong; Huang, Jie; Jiang, Jie; Li, Jian; Yang, Guoping; Cui, Yimin |
| 2-Jan-2020 | The effect of smoking on residual platelet reactivity to clopidogrel: a systematic review and meta-analysis | Liu, Zhiyan; Xiang, Qian; Mu, Guangyan; Xie, Qiufen; Zhou, Shuang; Wang, Zining; Chen, Shuqing; Hu, Kun; Gong, Yanjun; Jiang, Jie; Cui, Yimin |
| 2019 | Effectiveness and Safety of Platelet ADP-P2Y 12 Receptor Inhibitors Influenced by Smoking Status: A Systematic Review and Meta-Analysis | Liu, Zhiyan; Xiang, Qian; Mu, Guangyan; Xie, Qiufen; Zhou, Shuang; Wang, Zining; Chen, Shuqing; Hu, Kun; Gong, Yanjun; Jiang, Jie; Cui, Yimin |
| 2019 | Effects of CYP2C8 and SLCO1B1 Genetic Polymorphisms on Repaglinide Pharmacokinetics: A Systematic Review and Meta-Analysis | Zhou, Shuang; Xiang, Qi; Mu, Guangyan; Ma, Lingyue; Chen, Shuqing; Xie, Qiufen; Zhang, Zhuo; Cui, Yimin |
| Jun-2024 | Effects of PCSK9 on thrombosis and haemostasis in a variety of metabolic states: Lipids and beyond (Review) | Chong, Shan; Mu, Guangyan; Cen, Xinan; Xiang, Qian; Cui, Yimin |
| Feb-2020 | Efficacy and Safety of PCSK9 Monoclonal Antibodies in Patients at High Cardiovascular Risk: An Updated Systematic Review and Meta-Analysis of 32 Randomized Controlled Trials | Mu, Guangyan; Xiang, Qian; Zhou, Shuang; Liu, Zhiyan; Qi, Litong; Jiang, Jie; Gong, Yanjun; Xie, Qiufen; Wang, Zining; Zhang, Hanxu; Huo, Yong; Cui, Yimin |
| Nov-2022 | Ferroptosis of Endothelial Cells in Vascular Diseases | Zhang, Hanxu; Zhou, Shuang; Sun, Minxue; Hua, Manqi; Liu, Zhiyan; Mu, Guangyan; Wang, Zhe; Xiang, Qian; Cui, Yimin |
| Oct-2022 | Genetic Polymorphisms Associated with Prothrombin Time and Activated Partial Thromboplastin Time in Chinese Healthy Population | Zhang, Fan; Mu, Guangyan; Liu, Zhiyan; Xie, Qiufen; Zhang, Hanxu; Zhou, Shuang; Wang, Zhe; Hu, Kun; Wang, Zining; Zhao, Xia; Cui, Yimin; Xiang, Qian |
| Jul-2023 | Genetic polymorphisms of TMEM51 influenced the risk of bleeding by ticagrelor pharmacodynamics | Wang, Zhe; Xiang, Qian; Liu, Zhiyan; Mu, Guangyan; Zhou, Shuang; Zhang, Hanxu; Cui, Yimin |
| May-2023 | Genetic variants influenced the risk of bleeding and pharmacodynamics of rivaroxaban in patients with nonvalvular atrial fibrillation: A multicentre prospective cohort study | Xiang, Qian; Wang, Zhe; Mu, Guangyan; Xie, Qiufen; Liu, Zhiyan; Zhou, Shuang; Zhang, Hanxu; Wang, Zining; Jiang, Jie; Hu, Kun; Zhang, Yatong; Zhao, Zinan; Yuan, Dongdong; Guo, Liping; Wu, Tingting; Zhang, Jinhua; Wang, Na; Xiang, Jing; Gu, Zhichun; Sun, Jianjun; Cui, Yimin |
| May-2023 | Genetic variants influenced the risk of bleeding and pharmacodynamics of rivaroxaban in patients with nonvalvular atrial fibrillation: A multicentre prospective cohort study | Xiang, Qian; Wang, Zhe; Mu, Guangyan; Xie, Qiufen; Liu, Zhiyan; Zhou, Shuang; Zhang, Hanxu; Wang, Zining; Jiang, Jie; Hu, Kun; Zhang, Yatong; Zhao, Zinan; Yuan, Dongdong; Guo, Liping; Wu, Tingting; Zhang, Jinhua; Wang, Na; Xiang, Jing; Gu, Zhichun; Sun, Jianjun; Cui, Yimin |
